![]() |
|
![]() |
|
Clinical data | |
---|---|
Routes of administration |
oral |
Legal status | |
Legal status |
|
Identifiers | |
|
|
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
Chemical and physical data | |
Formula | C10H14FN |
Molar mass | 167.223 g/mol |
3D model (Jmol) | |
|
|
|
|
![]() ![]() |
2-Fluoromethamphetamine (2-FMA) is a stimulant drug from the amphetamine family which has rarely been found possessed as a designer drug. Effects include euphoria, loss of appetite, increased energy, insomnia, focus enhancement, bronchodialation, motivation enhancement, and dry mouth.
It is often compared by its users in anecdotal reports to Lisdexamfetamine (Vyvanse) in regards to 2-FMA's dosage, duration, and general effects profile. What is unique to 2-FMA is that even though it is chemically related to Methamphetamine, it does not share the same effects profile and is more comparable to Dextroamphetamine or Lisdexamfetamine . Compared against most pharmaceutical amphetamine formulations, it produces noticeably fewer physical side-effects, such as minimal nausea, negligible effects on anxiety, and lack of uncomfortable off-set of effects ('comedown).
As of October 2015 2-FMA is a controlled substance in China.